Lumos Pharma | Ativo Circulante



Ativo Circulante Alterar Data
Agenus USD 133.95M 120.61M 2025-09
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Capricor Therapeutics USD 100.95M 23.18M 2025-09
Celldex Therapeutics USD 604.34M 44.06M 2025-09
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 88.92M 8.72M 2025-09
CSL USD 11.85B 542M 2025-06
Eli Lilly USD 55.63B 6.44B 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
Merck USD 47.56B 10.49B 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Prothena USD 339.97M 45.51M 2025-09
Sarepta Therapeutics USD 2.72B 65.32M 2025-09


Lumos Pharma Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.